Mental health symptom associations with COVID-19 testing and vaccination among urban American Indian and Alaska Native people [0.03%]
城市美国原住民和阿拉斯加原住民的COVID-19检测和疫苗接种与心理健康症状之间的联系
Cole Haskins,Carolyn Noonan,Richard MacLehose et al.
Cole Haskins et al.
Background: The COVID-19 pandemic has substantially impacted American Indian and Alaska Native (AI/AN) communities. Rates of infection, hospitalization, and mortality have been severe relative to non-Hispanic whites. Whil...
Trust in health workers and patient-centeredness of care were strongest factors associated with vaccination for Kenyan children born between 2017-2022 [0.03%]
2017年至2022年肯尼亚出生的儿童接种疫苗最强相关的因素是信任卫生工作者和以患者为中心的护理
Corrina Moucheraud,Eric Ochieng,Vitalis Ogutu et al.
Corrina Moucheraud et al.
Objective: Although vaccination confidence is declining globally, there is little detailed information from low- and middle-income countries about factors influencing routine vaccination behavior in these contexts. ...
Young Hwa Lee,Young June Choe
Young Hwa Lee
Background: The introduction of varicella vaccination has significantly reduced the burden of chickenpox in many countries, but outbreaks still occur in populations with high vaccination coverage. To address this, some co...
Influenza virus circulation and vaccine effectiveness during June 2021-May 2023 in Thailand [0.03%]
2021年6月至2023年5月泰国流感病毒流行情况及疫苗效果研究
Kriengkrai Prasert,Prabda Praphasiri,Sutthichai Nakphook et al.
Kriengkrai Prasert et al.
Thai Ministry of Public Health recommends influenza vaccination for certain risk groups. We evaluated 2023 Southern Hemisphere influenza vaccine effectiveness against medically attended influenza using surveillance data from nine Thai hospi...
Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study [0.03%]
通过被动监测系统评估HPV4和HPV9疫苗在2008年至2022年期间的安全性：一项为期15年的回顾性观察研究
Diana Dalla Valle,Roberto Benoni,Nicola Soriolo et al.
Diana Dalla Valle et al.
In Veneto Region, HPV vaccine has been actively offered to 12 year-old females since 2008, and to 12 year-old males since 2015. The study aims to analyze the safety profile of HPV4v and HPV9v vaccines and perform a case-by-case review of co...
Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2 [0.03%]
新冠病毒感染分别在接种mRNA新冠疫苗BNT162b2之前和之后提供的有效性和持续时间的额外免疫防护作用分析
Nagashige Shimada,Satoshi Sugawa,Satoshi Murakami et al.
Nagashige Shimada et al.
Background: Our investigation focused whether infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before or after receiving the mRNA COVID-19 vaccine can increase immune protection. And we also inv...
A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany) [0.03%]
在德国美因茨的成人医护人员中开展CVnCoV(新冠病毒mRNA疫苗) I/II期概念验证、随机、观察者盲法和安慰剂对照试验，以评估该疫苗的安全性和免疫原性
Frank Kowalzik,Daniel Teschner,Margarida Mesquita et al.
Frank Kowalzik et al.
Background: CV-NCOV-005 was conducted to generate additional safety and immunogenicity data for the former CVnCoV SARS-CoV-2 mRNA vaccine candidate in healthcare workers (HCW). ...
Adverse events of COVID-19 vaccination during 2021-2022 suppressed by breakfast consumption and favorable sleeping habit among Japanese university students [0.03%]
2021—2022年日本大学生接种新冠疫苗不良事件受到早餐摄入和良好睡眠习惯影响的回顾性研究
Nobuyuki Tetsuka,Keiko Suzuki,Kodai Suzuki et al.
Nobuyuki Tetsuka et al.
Introduction: Young adults are hesitant to receive the coronavirus disease 2019 (COVID-19) vaccination owing to concerns regarding adverse events despite the effectiveness of vaccines in preventing SARS-CoV-2 infection-as...
Exploring COVID-19 vaccine hesitancy among young adults in Australia. A qualitative study [0.03%]
澳大利亚年轻人新冠肺炎疫苗犹豫定性研究
Zachary Sum,Ernesta Sofija,Bernadette Sebar
Zachary Sum
Background: COVID-19 vaccine hesitancy among young adults in Australia is still poorly understood. Young adults aged 25-34 years have been identified as a population subgroup where COVID-19 vaccine-hesitant views are high...
Why did I participate in an HIV vaccine study? Experiences of participation in the first phase II HIV vaccine trial in Mozambique: An ancillary study using a mixed-method approach [0.03%]
为什么我会参与艾滋病毒疫苗研究？——在莫桑比克进行第一次II期艾滋病疫苗试验的研究参与者经历：一种混合方法的辅助研究
Igor P Ubisse Capitine,Álvaro Marcela Manhiça,Paulo Tembe Júnior et al.
Igor P Ubisse Capitine et al.
Introduction: This study recognized the lack of information regarding recruitment and retention factors associated with implementing HIV vaccine trials from the perspective of de facto participants. It aimed to describe t...